Reset filter
Palavras-chave
LABORATORIJI ×
Mostrar mais Palavras-chave
Índice
  1. 1. Estudo clínico
  2. 2. Documentação de rotina
  3. 3. Estudos de registo/coortes
  4. 4. Garantia da qualidade
  5. 5. Padrão de dados
  6. 6. Questionário do paciente
  7. 7. Especialidade médica
Modelos de dados selecionados

Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.

1061 Resultados da pesquisa.
Relevância Avaliação Novos primeiro Antigos primeiro

Top 300 Dataset of the Medical Informatics Initiative Germany (MII) - Laboratory Tests (Overview)

- 29/04/2019 - 1 Formulário, 1 Grupo de itens, 300 Elementos de dados, 2 Idiomas
Grupo de itens: Laboratory Tests
The Top 300 Dataset (Kerndatensatz Labor) was developed by the Medical Informatics Initiative Germany (MII) and contains frequency-sorted, LOINC-coded analyses of the university clinics in Göttingen, Gießen, Munich, Greifswald and Erlangen. This form shows an overview of the preferred presentation of the most common laboratory parameters. Official german translations were used where available. https://www.medizininformatik-initiative.de/de/labordaten-in-der-medizininformatik-initiative Explanation of abbreviations (english / german): Bld = Blood / Blut BldA = arterial blood / arterielles Blut Ser = Serum / Serum Plas = Plasma / Plasma RBC = Red blood cells / Erythrozyten PPP = Platelet poor plasma / plättchenarmes Plasma Urine sed = Urine sediment / Urinsediment CSF = Cerebral spinal fluid / Liquor Body fld = Body fluid / Körperflüssigkeit

EHR4CR CTE Data Inventory

- 21/04/2018 - 1 Formulário, 14 Grupos de itens, 133 Elementos de dados, 1 Idioma
Grupos de itens: Adverse Events, Concomitant Medication, Demographics, Disease Characteristics, Disposition, ECG, Laboratory, Laboratory Data, Medical History, Patient Reported Outcome, Substance Use, Surgery, Tumor Response, Vital Signs
Data Inventory for Clinical Trial Execution in the EHR4CR project. https://www.ncbi.nlm.nih.gov/pubmed/27875988 DOI for citation: 10.21961/MDM:17994

Lab tests cardiac surgery UKM - Lab tests

- 10/07/2017 - 1 Formulário, 2 Grupos de itens, 22 Elementos de dados, 2 Idiomas
Grupos de itens: Patient demographics, Lab tests
Lab tests form converted to ODM format. Routine documentation of University Hospital of Münster. Publication granted by Univ.-Prof. Dr. med. Sven Martens.

CDASH Lab Result Assessment (Scenario 3, Part 2) - CDASH LAB Result Assessment (Scenario 3, Part 2)

- 20/09/2021 - 1 Formulário, 1 Grupo de itens, 2 Elementos de dados, 2 Idiomas
Grupo de itens: LAB Abnormal result
modified from http://www.cdisc.org

26672_Common Data Elements Myeloid Leukemia (MDS AML CML) - Global Disease Course

- 20/09/2021 - 13 Formulários, 3 Grupos de itens, 11 Elementos de dados, 1 Idioma
Grupos de itens: Global Disease Course, Red Cell Transfusion, Platelet Cell Transfusion
Common Data Elements Myeloid Leukemia (MDS, AML, CML) for use in clinical routine and clinical trial documentation. https://www.ncbi.nlm.nih.gov/pubmed/27577388

Physical Examination/Follow up

3 Grupos de itens 14 Elementos de dados

Administrative/Demographic Details

1 Grupo de itens 11 Elementos de dados

Medical History

3 Grupos de itens 9 Elementos de dados

Lab: Cytology/Cytogenetics/Cytochemistry

1 Grupo de itens 29 Elementos de dados

Lab: Immunophenotyping

1 Grupo de itens 17 Elementos de dados

Lab: Molecular Genetics

1 Grupo de itens 27 Elementos de dados

Efficacy and Safety of Eltrombopag in Thrombocytopenic Subjects With Hepatitis C Virus Lab panels NCT00516321

- 20/09/2021 - 1 Formulário, 6 Grupos de itens, 71 Elementos de dados, 1 Idioma
Grupos de itens: Chemistry, Haematology, Liver Chemistry Assessments, Renal Laboratory Parameters, Urinalysis Dipstick, Other Laboratory Screenings
The purpose of this study is to assess the ability of eltrombopag to maintain a platelet count sufficient to facilitate initiation of antiviral therapy, to minimise antiviral therapy dose reductions and to avoid permanent discontinuation of antiviral therapy. The clinical benefit of eltrombopag will be measured by the proportion of subjects who are able to achieve a Sustained Virological Response (SVR). NCT00516321 https://clinicaltrials.gov/ct2/show/NCT00516321 Study Type: Interventional Study Design: Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor) Primary Purpose: Treatment Official Title: Randomised, Placebo-controlled, Multi-centre Study to Assess the Efficacy and Safety of Eltrombopag in Thrombocytopenic Subjects With Hepatitis C Virus (HCV) Infection Who Are Otherwise Eligible to Initiate Antiviral Therapy (Peginterferon Alfa-2a Plus Ribavirin

Efficacy and Safety of Eltrombopag in Thrombocytopenic Subjects With Hepatitis C Virus Lab Panels NCT00529568

- 20/09/2021 - 1 Formulário, 6 Grupos de itens, 72 Elementos de dados, 1 Idioma
Grupos de itens: Chemistry, Haematology, Liver Chemistry Assessments, Renal Laboratory Parameters, Urinalysis Dipstick, Other Laboratory Screenings
The purpose of this study is to assess the ability of eltrombopag to maintain a platelet count sufficient to facilitate initiation of antiviral therapy, to minimise antiviral therapy dose reductions and to avoid permanent discontinuation of antiviral therapy. The clinical benefit of eltrombopag will be measured by the proportion of subjects who are able to achieve a Sustained Virological Response (SVR). NCT00529568 https://clinicaltrials.gov/ct2/show/NCT00529568 Study Type: Interventional Study Design: Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Participant, Investigator) Primary Purpose: Treatment Official Title: Randomised, Placebo-controlled, Multi-centre Study to Assess the Efficacy and Safety of Eltrombopag in Thrombocytopenic Subjects With Hepatitis C Virus (HCV) Infection Who Are Otherwise Eligible to Initiate Antiviral Therapy (Peginterferon Alfa-2b Plus Ribavirin)

Safety and Efficacy of Eltrombopag in Thrombocytopenic Subjects With Hepatitis C Virus Infection Lab panels NCT00996216

- 20/09/2021 - 1 Formulário, 6 Grupos de itens, 49 Elementos de dados, 1 Idioma
Grupos de itens: Clinical Chemistry, Haematology, Liver Chemistry, Renal Assessments, Urinalysis Dipstick, Other Laboratory Screenings
The purpose of this study is to test the safety and tolerability of eltrombopag when used to increase and maintain platelet count. Platelet count to be maintained at a level sufficient to facilitate initiation of antiviral therapy, to minimize antiviral therapy dose reductions, and to avoid permanent discontinuation of antiviral therapy. NCT00996216 https://clinicaltrials.gov/ct2/show/NCT00996216 Study Type: Interventional Study Design: Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment Official Title: An Open-label, Multi-centre Rollover Study to Assess the Safety and Efficacy of Eltrombopag in Thrombocytopenic Subjects With Hepatitis C Virus (HCV) Infection Who Are Otherwise Eligible to Initiate Antiviral Therapy (Peginterferon Alfa-2a or Peginterferon Alfa-2b Plus Ribavirin)

EHR4CR Complete Data Inventory - EHR4CR Data Inventory

- 10/02/2017 - 1 Formulário, 13 Grupos de itens, 122 Elementos de dados, 1 Idioma
Grupos de itens: Demographics, Diagnoses and Procedures, Vital Signs, Laboratory, Generic Laboratory Data, Medication, Adverse Events, Medical History, Clinical Findings, ECG, Patient Reported Outcome, Substance Use, Study Participation Status
Compilation of Feasibility, Patient Identification & Recruitment and Clinical Trial Execution data inventories. https://www.ncbi.nlm.nih.gov/pubmed/24410735 https://www.ncbi.nlm.nih.gov/pubmed/25991199 https://www.ncbi.nlm.nih.gov/pubmed/27875988

Study SHIP-START_SHIP2_LAB - s2.urin_status

- 26/10/2024 - 12 Formulários, 1 Grupo de itens, 12 Elementos de dados, 2 Idiomas
Grupo de itens: s2.urin_status
SHIP Study https://doi.org/10.1093/ije/dyac034

s2.i_scn_no3

1 Grupo de itens 22 Elementos de dados

s2.cral

1 Grupo de itens 7 Elementos de dados

s2.klbb

1 Grupo de itens 10 Elementos de dados

s2.glyk

1 Grupo de itens 1 Elemento de dados

s2.geri

1 Grupo de itens 15 Elementos de dados

s2.espr

1 Grupo de itens 16 Elementos de dados

Study SHIP-TREND_TREND1_LAB - t1.prostate

- 26/10/2024 - 15 Formulários, 1 Grupo de itens, 7 Elementos de dados, 2 Idiomas
Grupo de itens: t1.prostate
SHIP Study https://doi.org/10.1093/ije/dyac034

t1.klbb

1 Grupo de itens 10 Elementos de dados

t1.glyk

1 Grupo de itens 2 Elementos de dados

t1.geri

1 Grupo de itens 11 Elementos de dados

t1.espr

1 Grupo de itens 21 Elementos de dados

t1.thyr

1 Grupo de itens 16 Elementos de dados

t1.diff

1 Grupo de itens 41 Elementos de dados

Study SHIP-TREND_TREND0_LAX - t0.xtd_metabo

- 26/10/2024 - 14 Formulários, 1 Grupo de itens, 9 Elementos de dados, 2 Idiomas
Grupo de itens: t0.xtd_metabo
SHIP Study https://doi.org/10.1093/ije/dyac034

t0.xtd_rheuma

1 Grupo de itens 3 Elementos de dados

t0.merckpanel

1 Grupo de itens 47 Elementos de dados

t0.omics_tma

1 Grupo de itens 10 Elementos de dados

t0.xtd_omics

1 Grupo de itens 3 Elementos de dados

t0.xtd_espr

1 Grupo de itens 5 Elementos de dados

t0.prot

1 Grupo de itens 1 Elemento de dados

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial